MIRA Valuation
Mira Pharmaceuticals Inc
$
1.290
- Overview
- Forecast
- Valuation
MIRA Relative Valuation
MIRA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MIRA is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
9.03
P/B
Median3y
11.38
Median5y
11.38
-28.27
FCF Yield
Median3y
-24.61
Median5y
-24.61
Competitors Valuation Multiple
The average P/S ratio for MIRA's competitors is 1.10, providing a benchmark for relative valuation. Mira Pharmaceuticals Inc Corp (MIRA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch
MTW
Manitowoc Company Inc
9.820
USD
+14.72%
RLGT
Radiant Logistics Inc
6.030
USD
+1.17%
GOCO
Gohealth Inc
8.340
USD
-1.77%
LPA
Logistic Properties of The Americas
6.400
USD
+4.58%
MEC
Mayville Engineering Company Inc
14.360
USD
+11.75%
XOMA
XOMA Corp
24.210
USD
-1.10%
OB
Outbrain Inc
3.530
USD
+4.75%
CRVS
Corvus Pharmaceuticals Inc
3.350
USD
+4.69%
TTSH
Tile Shop Holdings Inc
6.030
USD
+11.67%
FSBW
FS Bancorp Inc
40.010
USD
+0.93%
FAQ
Is Mira Pharmaceuticals Inc (MIRA) currently overvalued or undervalued?
Mira Pharmaceuticals Inc (MIRA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Mira Pharmaceuticals Inc (MIRA) is between to according to relative valuation methord.
What is Mira Pharmaceuticals Inc (MIRA) fair value?
How does MIRA's valuation metrics compare to the industry average?
What is the current P/B ratio for Mira Pharmaceuticals Inc (MIRA) as of May 08 2025?
What is the current FCF Yield for Mira Pharmaceuticals Inc (MIRA) as of May 08 2025?
What is the current Forward P/E ratio for Mira Pharmaceuticals Inc (MIRA) as of May 08 2025?